About NovaLead Pharma
NovaLead Pharma is a company based in Pune (India) founded in 2007 by Ajay Aslekar, Girish Lakhe, Sayali Aslekar, Prerna Deshpande, Atul Aslekar, and Supreet Deshpande.. NovaLead Pharma has raised $8.04 million across 4 funding rounds from investors including Tata Capital Healthcare Fund, Boxmoor Mauritius and BIRAC. NovaLead Pharma operates in a competitive market with competitors including Aclaris Therapeutics, BiomX, Alumis, Elektrofi and Rani Therapeutics, among others.
- Headquarter Pune, India
- Founders Ajay Aslekar, Girish Lakhe, Sayali Aslekar, Prerna Deshpande, Atul Aslekar, Supreet Deshpande
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Novalead Pharma Private Limited
- Date of Incorporation 31 Oct, 2007
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$705.86 K (USD)513.86as on Mar 31, 2023
-
Net Profit
$413.23 K (USD)353.23as on Mar 31, 2023
-
EBITDA
$-33.24 K (USD)53.09as on Mar 31, 2023
-
Total Equity Funding
$8.04 M (USD)
in 4 rounds
-
Latest Funding Round
$3.15 M (USD), Series B
Jul 17, 2015
-
Investors
Tata Capital Healthcare Fund
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NovaLead Pharma
NovaLead Pharma has successfully raised a total of $8.04M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $3.15 million completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $3.2M
-
First Round
First Round
(31 Aug 2010)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2015 | Amount | Series B - NovaLead Pharma | Valuation | TCHF | |
| Jun, 2015 | Amount | Grant - NovaLead Pharma | Valuation |
investors |
|
| Nov, 2011 | Amount | Series A - NovaLead Pharma | Valuation | Boxmoor Mauritius |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NovaLead Pharma
NovaLead Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Tata Capital Healthcare Fund, Boxmoor Mauritius and BIRAC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund investing in healthcare and lifesciences in India.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Business incubation services are provided across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NovaLead Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NovaLead Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novalead Pharma Comparisons
Competitors of NovaLead Pharma
NovaLead Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aclaris Therapeutics, BiomX, Alumis, Elektrofi and Rani Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Microbiome therapeutics are developed for dysbiosis-linked diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for autoimmune diseases are developed by Alumis.
|
|
| domain | founded_year | HQ Location |
Digital platform transforming the delivery of biologic medicines
|
|
| domain | founded_year | HQ Location |
Technology for oral delivery of large drug molecules is developed.
|
|
| domain | founded_year | HQ Location |
Developer of biosimilar drugs for the treatment of multiple diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novalead Pharma
Frequently Asked Questions about NovaLead Pharma
When was NovaLead Pharma founded?
NovaLead Pharma was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Where is NovaLead Pharma located?
NovaLead Pharma is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Who is the current CEO of NovaLead Pharma?
Supreet Deshpande is the current CEO of NovaLead Pharma. They have also founded this company.
Is NovaLead Pharma a funded company?
NovaLead Pharma is a funded company, having raised a total of $8.04M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.12M, raised on Aug 31, 2010.
What is the annual revenue of NovaLead Pharma?
Annual revenue of NovaLead Pharma is $705.86K as on Mar 31, 2023.
What does NovaLead Pharma do?
NovaLead Pharma was founded in 2007 in Pune, India, within the pharmaceutical sector. Drug repurposing and discovery services are delivered through a proprietary technology platform. Key developments include Galnobax, a topical esmolol gel for diabetic foot ulcers, and NLP91, a repurposed generic for psoriasis treatment. Operations center on biotech innovation and therapeutic applications in dermatology and wound care.
Who are the top competitors of NovaLead Pharma?
NovaLead Pharma's top competitors include Elektrofi, Aclaris Therapeutics and Samsung Bioepis.
Who are NovaLead Pharma's investors?
NovaLead Pharma has 3 investors. Key investors include Tata Capital Healthcare Fund, Boxmoor Mauritius, and BIRAC.
What is NovaLead Pharma's valuation?
The valuation of NovaLead Pharma is $30.96M as of Jul 2015.